Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

BACKGROUND: In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therap...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Heart Assoc
Hoofdauteurs: Foley, Michael, Rajkumar, Christopher A., Shun‐Shin, Matthew, Ganesananthan, Sashiananthan, Seligman, Henry, Howard, James, Nowbar, Alexandra N., Keeble, Thomas R., Davies, John R., Tang, Kare H., Gerber, Robert, O’Kane, Peter, Sharp, Andrew S. P., Petraco, Ricardo, Malik, Iqbal S., Nijjer, Sukhjinder, Sen, Sayan, Francis, Darrel P., Al‐Lamee, Rasha
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2021
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955412/
https://ncbi.nlm.nih.gov/pubmed/33496201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017381
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items